Blog
Planify news
Fortis board gives nod for diagnostic arm IPO, net profit drops 9% in Q1 FY24
Link copied
Fortis board gives nod for diagnostic arm IPO, net profit drops 9% in Q1 FY24
04 August 2023
Fortis Healthcare board on Friday approved its diagnostic arm Agilus to initiate an initial public offer process, by way of an offer for sale by the latter's existing and eligible shareholders in the IPO. Agilus was earlier called SRL Diagnostics, which was rebranded in May this year.
Fortis Healthcare board on Friday approved its diagnostic arm Agilus to initiate an initial public offer process, by way of an offer for sale by the latter's existing and eligible shareholders in the IPO. Agilus was earlier called SRL Diagnostics, which was rebranded in May this year.
Stay Connected, Stay Informed –
Join Our
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.